review of glp 1 GLP-1 receptor agonists show promise in treating substance use disorders What Happens After GLP-1 Weight

November 14th, 2025: Three New Jersey Cases Added to Expanding GLP-1 Drug MDL A federal judicial panel has transferred three additional lawsuits from New Jersey into the growing multidistrict litigation involving claims that Eli Lilly and Novo Nordisk minimized the safety risks associated with GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Trulicity

These functional improvements represent the transformation that matters most for quality of life

Why Anthem coverage varies so dramatically Understanding why two Anthem members can have completely different coverage requires understanding how health insurance actually works in the United States

Theyre gonna slow down your digestion, theyre gonna make you feel full, and if you combine that with eating nutrient-dense foods that are more full of water and fiber and protein, youre gonna feel full on smaller amounts of food and youll lose more weight with the medication. And if youre close to the threshold but not over it